Acorda Therapeutics

DCJones (jones(AT)tdl.com)
Mon, 03 Nov 1997 16:24:07 -0800

Web surched Acorda Therapeutics for investment and found this. Some
interesting and hopeful reading. No mention of AP4 but the artical is
dated June of 95, which makes it that much more hopeful!
Typically a company that enters phase II of AMA trials has 50/50 chance
of getting approval to go to phase III. "considering they have possitive
results" If they pass phase II and enter phase III it's 90/10 they'll be
approved.

Here's hope'n; Dave

http://www.enews.com/magazines/geng_news/archive/061595.1.html